Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials
Daniel J. Benedetti, Nicholas G. Cost, Peter F. Ehrlich, Nicholas F. Evageliou, Elizabeth Fialkowski, Lauren Parsons, Kelly Vallance, Lindsay A. Renfro, Andrew L. Hong, Jennifer H. Aldrink, Luke Pater, Arnold C. Paulino, Jesse K. Sandberg, Ethan A. Smith, Amy Treece, Jeffrey S. Dome, James I. Geller, Elizabeth A. Mullen
Topics & Concepts
MedicineRisk stratificationClinical trialWilms tumourWilms' tumorCogOncologyInternal medicineIntensive care medicineArtificial intelligenceComputer scienceRenal and related cancersEthics and Legal Issues in Pediatric Healthcare